OncoSec Medical Inc (ONCSQ)

[TomP1]

The clinical studies are anything but meaningless as they are designed to validate a concept.
You do not do that with hundreds of patients. Once the hypothesis is proven, then you take it fom there

We know the mono works in melanoma. It will be tested in triple negative breast and head and neck.
Furthermore ONCS will test wether a combination with Keytruda yields better ORR or not. Coupke this with biomarkers to pretest a patient (Plexikon and Heat)

Last but not least, R&D ito a new electroporation device that can go anyway.

So yes ONCS has a lot of balls in the air